Introduction {#Sec1}
============

American Tegumentary Leishmaniasis (ATL) is a vector-borne parasitic disease caused by *Leishmania* protozoan that is characterized by lesions of the skin and oral or nasopharyngeal mucosa. Among the species of *Leishmania* and *Viannia* subgenus, *L*. (*L*.) *amazonensis* and *L*. (*V*.) *braziliensis* cause ATL leading to different clinical forms, which are dependent on the parasite species and the immune system of the host^[@CR1]^. Both *L. amazonensis* and *L. braziliensis* can cause localized cutaneous leishmaniasis (LCL). In the most severe cases of Leishmaniasis, *L. amazonensis* can cause diffuse cutaneous lesions (DCL) and *L. braziliensis* can cause mucocutaneous lesions (ML)^[@CR2]^.

Innate immune cells such as macrophages, neutrophils, and natural killer cells recognize microorganisms through interaction between microbial ligands (MAMPs) with their pattern recognition receptors (PRRs). These PRRs include Toll-like receptors (TLRs) and NOD-like receptors (NLRs)^[@CR3],[@CR4]^. The *Leishmania* membrane has lipophosphoglycans (LPG), glycoinositolphospholipids (GIPLs), and glycoprotein 63 (gp63) as the main molecules that are recognized by innate immune cells^[@CR5],[@CR6]^. Recent studies have shown the involvement of TLRs in recognizing some of these molecules. LPG and GIPLs are recognized by TLR4 and TLR2, respectively. TLR9 also plays a role in recognizing the DNA of *Leishmania* spp. These mechanisms lead to induction of cytokines and microbicidal molecules after exposure to *Leismania* spp.^[@CR7]--[@CR11]^. In addition to, NLRs are important receptors for recognition of several microorganisms^[@CR12]^. However, few studies have described their role in *Leishmania* recognition. Lima Junior *et al* ^[@CR13]^ have shown that the NLRP3 inflammasome plays an important protective role during *L. amazonensis* infection in a mouse model. Conversely, it was showed that NLRP3 activation followed by IL-1β production mediates the detrimental CD8^+^ T cell-mediated cytotoxicity in tegumentary leishmaniasis, causing lesions/chronic inflammation in mouse model of infections caused by *L. braziliensis* or *L. major* ^[@CR14]^. NLRP3 can also contribute to mouse susceptibility to *L. major* by increasing neutrophils recruitment, which plays a crucial role in the development of nonhealing lesions^[@CR15]^. Recently, in patients with visceral leishmaniasis and in a murine infection model with *L. infantum*, the NOD2-RIPK2 pathway has been found to be involved in the development of the Th1-type response^[@CR16]^, the most important response against *Leishmania* spp. Because the innate immune response is important in driving the acquired immune response, the efficient recognition of the parasite by PRRs improves the host resistance^[@CR16]^.

*Leishmania* recognition by monocytes or macrophages through TLRs leads to the production of proinflammatory cytokines such as tumor necrosis factor (TNFα), interleukin (IL)-6, and interferon gamma (IFNγ), which all contribute for the exacerbated inflammation in leishmaniasis lesions^[@CR11],[@CR17]--[@CR19]^. Following NLRP3 inflammasome activation, IL-1β can be produced and contributes to the control of murine *Leishmania* infection^[@CR13]^. Besides inflammation, these proinflammatory cytokines are important for controlling the *Leishmania* infection by inducing microbicidal molecules, such as reactive oxygen and nitrogen intermediates (ROI, RNI), which are crucial for the parasite killing^[@CR10],[@CR19]--[@CR22]^.

Since it is known that the immunogenetic background of the patients is one of the most important factors to determine the clinical outcome of leishmaniasis^[@CR23]^, we investigated the role of genetic variants in genes of the NLR family for the *Leishmania*-induced immune response.

Results {#Sec2}
=======

Individuals heterozygous for *NOD2* mutation produce less cytokines after *Leishmania* spp. exposure compared to individuals with wild-type *NOD2* {#Sec3}
--------------------------------------------------------------------------------------------------------------------------------------------------

We explored whether SNPs in NLR family members NOD1 and NOD2 influence the production of cytokines after stimulation with *Leishmania* parasites. Through these analyses, we found that the NOD2 receptor plays an important role in the immune response against *Leishmania* spp. (Fig. [1](#Fig1){ref-type="fig"}). The results demonstrated that individuals heterozygous for *NOD2* Leu1007insC polymorphism displayed significantly lower production of TNFα, IL-1β, IL-6, IL-8 and IFNγ for either *L*. *amazonensis* or *L. braziliensis* stimulation (Fig. [1A,B](#Fig1){ref-type="fig"}). Interestingly, NOD2 was only important for IL-17 induced by *L*. *amazonensis*, while *L. braziliensis* practically did not induce IL-17 production (Fig. [1B](#Fig1){ref-type="fig"}). Confirming the relevance of this *NOD2* mutation for cytokine induction, the NOD2 agonist MDP induced lower cytokine production when added to PBMCs from individuals with the Leu1007insC variance, compared to the control subjects (Fig. [1A](#Fig1){ref-type="fig"}). Evaluation of other common polymorphisms in the *NOD2* gene revealed no differences in the *Leishmania*-induced cytokine production (Figs [S1](#MOESM1){ref-type="media"} and 2). In addition to *NOD2*, we also investigated whether the *NOD1* receptor could play a role in the cytokine induction after *Leishmania* exposure. In contrast to NOD2, no differences in monocyte- or lymphocyte-derived cytokine production were noted when PBMCs homozygous for *NOD1* Glu796Lys were stimulated with *L. amazonensis* or *L. braziliensis* (Fig. [1C](#Fig1){ref-type="fig"}). Using the NOD1 agonist FK156, we demonstrated that Glu796Lys variance results in loss of function of NOD1 (Fig. [1C](#Fig1){ref-type="fig"}).Figure 1*NOD2* but not *NOD1* plays an important role in monocyte-and lymphocyte-derived cytokines induced by after *Leishmania* pecies stimulation. Peripheral blood mononuclear cells (PBMCs, 5 × 10^5^ cells/100 μL) from healthy individuals genotyped for *NOD1* (Glu796Lys) and *NOD2* (1007finsC) were stimulated with different stimuli including lysates of *Leishmania* spp. (50 μg/mL, *L*. (*L*.) *amazonensis*: *L. amaz*; *L*. (*V*.) *braziliensis*: *L. braz*), FK156 (10 μg/mL), MDP (10 μg/mL); Medium: non-stimulated cells. TNFα, IL-6, IL-1β and IL-8 concentrations were measured in supernatants by ELISA after 24 h of incubation. IFNγ and IL-17 were determined after 7 days of incubation: the *NOD2* (**A** and **B**) and *NOD1* (**C**) genotype. Bars represent individuals carrying no SNP (wild type, Wt, white bars), heterozygous SNP carries (He, black bars), or homozygous variation (Ho, grey bars). Data represent the mean ± SEM. \*p \< 0.05; Mann-Whitney U-test (**A** and **B**; Wt vs He); (**C**; Wt vs Ho).

Phagolysosome formation is important for *Leishmania*-induced cytokine production and upregulation of *NOD2* mRNA expression {#Sec4}
----------------------------------------------------------------------------------------------------------------------------

In order to investigate whether *Leishmania* could upregulate the mRNA expression of *NOD2*, human PBMCs were incubated for 24 h with either parasite lysates or live promastigote forms of both *L. amazonensis* or *L. braziliensis*. The use of both forms of *Leishmania* stimuli was determined by the need to examine whether NOD2 is activated by *Leishmania* fragments which means that the parasites needs to be degraded intracellularly. Figure [2A](#Fig2){ref-type="fig"} showed that lysates as well as intact parasites of both *Leishmania* spp. were able to increase the *NOD2* mRNA expression but not *NOD1* mRNA. As positive controls FK-156 and MDP both could upregulation *NOD1* or *NOD2* mRNA expression respectively (Fig. [2A](#Fig2){ref-type="fig"}).Figure 2*Leishmania* species induce *NOD2* mRNA expression and phagolysosome formation is important for *Leishmania*-induced cytokine production. (**A** and **B**) Peripheral blood mononuclear cells (PBMCs, 5 × 10^5^ cells/100 μL) from healthy individuals were stimulated with either lysates (50 μg/mL) or promastigotes (1 × 10^5^ parasites) of *Leishmania* species (*L*. (*L*.) *amazonensis*: *L. amaz*; *L*. (*V*.) *braziliensis*: *L. braz)*; Medium (non-stimulated cells), FK156 (10 μg/mL), MDP (10 μg/mL) and LPS (10 ng/mL) were used as controls. (**B**) In some experiments cells were incubated in the absence (white) or presence (gray) of bafilomycin A1 (250 nM). Medium plus Vehicle (DMSO). (**A**) *NOD1* and *NOD2* mRNA expression were determined by quantitative real-time PCR after 24 h of incubation. (**B**) TNFα, IL-6 and IL-1β concentrations were determined in supernatants by ELISA after 24 h of incubation. Data represent the mean ± SEM, \*p \< 0.05; Wilcoxon test (**A**) (Medium vs stimuli) (**B**) (Vehicle vs Bafilomycin) (n = 6, in 2 independent experiments done in duplicates). (**C**) Embryonic kidney (HEK)-293 cells (1 × 10^6^ cells/100 µL) transfected or not with *NOD2* were stimulated for 24 h with lysates of *Leishmania* species (50 μg/mL) or promastigote forms (2 × 10^6^ parasites) in the stationary growth phase of *L. amaz*; *L. braz*. Medium, LPS (10 ng/mL), and MDP (10 μg/mL) were included as controls. Protein levels of IL-8 were determined by ELISA in supernatants. Data represent the mean ± SEM of three independent experiments, \*p \< 0.05; Paired t-test (HEK-293 vs HEK + NOD2).

To examine whether degradation of the parasite by the phagolysosome is essential for *Leishmania*-induced cytokine production we inhibited the formation of phagolysosomes. PBMCs were incubated in the absence or presence of bafilomycin A1, a chemical compound that prevents maturation of parasitophorus vacuoles by inhibiting fusion between phagosomes and lysosomes^[@CR24]^. Figure [2B](#Fig2){ref-type="fig"} shows a remarkable decrease in TNFα and IL-1β production after exposure to promastigote forms of either *L.amazonensis* and *L. braziliensis* in the presence of bafilomycin A1 (Fig. [2B](#Fig2){ref-type="fig"}). For IL-6, a decrease was observed after exposure to *L. amazonensis* and despite a tendency to reduction after exposure to *L. braziliensis* the difference did not achieve statistical significance (p = 0.0938). No differences in TNFα, IL-1β or IL-6 concentrations were observed when lysates of both *Leishmania* spp. were used to activate PBMCs in absence or presence of bafilomycin A1 (Fig. [2B](#Fig2){ref-type="fig"}).

To confirm the pivotal role of NOD2 in the recognition of *Leishmania*, HEK-293 cells overexpressing NOD2 were exposed to either lysates or live promastigote forms of either *L. amazonensis* or *L. braziliensis*. We observed a strong increase in IL-8 production after stimulation with either lysates or promastigote forms of *Leishmania* pecies when NOD2 was present in the HEK-293 cells (Fig. [2C](#Fig2){ref-type="fig"}). A similar effect in IL-8 production was observed when NOD2 agonist MDP was added as a positive control. A potent TLR4 agonist (LPS) was used as negative control, showing no elevated IL-8 production. To validate the HEK-293-NOD2 reporter cells, we determined *NOD2* mRNA expression before and after MDP exposure by quantitative real-time PCR (Fig. [S3](#MOESM1){ref-type="media"}).

PBMCs isolated from patients bearing *NOD2* (3020insC) mutation confirmed the crucial role of NOD2 for *Leishmania*-induced cytokine production {#Sec5}
-----------------------------------------------------------------------------------------------------------------------------------------------

Additional experiments were performed to confirm the role of NOD2 in *Leishmania* recognition. To this end, PBMCs carrying the *NOD2* frameshift (3020insC) mutation were stimulated with live parasites or lysates of parasites for 24 h. The production of cytokines was compared with PBMCs isolated from healthy individuals (wt). As expected, cytokine concentrations were complete absent in individuals homozygous for the 3020insC frameshift mutation when PBMCs where stimulated with MDP (Fig. [3A](#Fig3){ref-type="fig"}). LPS-induced cytokine production was similar between PBMCs isolated from subjects carrying the 3020insC frameshift mutation and healthy controls (Fig. [3A](#Fig3){ref-type="fig"}). Production of TNFα, IL-1β, IL-6, IL-8, IFNγ was significantly decreased in PBMCs bearing the *NOD2* 3020insC frameshift mutation compared to PBMCs of individuals without this mutation after exposure to lysates or promastigote forms of both *L. amazonensis* and *L. braziliensis* (Fig. [3A and B](#Fig3){ref-type="fig"}). Of high interest, a reduction of IL-17 production was only observed after exposure to *L. amazonensis* (Fig. [3B](#Fig3){ref-type="fig"}).Figure 3*NOD2* plays an important role in the cytokines after *Leishmania* stimulation. (**A**,**B**) Peripheral blood mononuclear cells (PBMCs, 5 × 10^5^ cells/100 μL) from healthy individuals (n = 8) carrying no mutation in *NOD2* (3020insC) (Wt; white bars) and from individuals carrying a mutation in *NOD2* receptor (n = 4; grey bars) were stimulated with either lysates (50 μg/mL) or promastigotes (1 × 10^5^ parasites) of *Leishmania* species (*L*. (*L*.) *amazonensis*: *L. amaz*; *L*. (*V*.) *braziliensis*: *L. braz)*; Medium (non-stimulated cells), MDP (10 μg/mL) and LPS (10 ng/mL) were used as controls. (**A**) TNFα, IL-6 and IL-1β concentrations were determined in supernatants by ELISA after 24 h incubation. (**B**) IFNγ and IL-17 were determined after 7 days of incubation in supernatants by ELISA; Data represent the mean ± SEM, \*p \< 0.05; Mann-Whitney U-test (Wt vs 3020insC). (**C**) Peripheral blood mononuclear cells (PBMCs, 5 × 10^5^ cells/100 μL) from healthy individuals were stimulated with either lysates (50 μg/mL) or promastigotes (1 × 10^5^ parasites) of *Leishmania* species (*L*. (*L*.) *amazonensis*: *L. amaz*; *L*. (*V*.) *braziliensis*: *L. braz)* in the presence (grey bars) or absence (white bars) of the Ponatinib (100 nM); Medium (non-stimulated cells) plus Vehicle (DMSO) and MDP (10 μg/mL) were used as controls. TNFα, IL-6 and IL-1β concentrations were determined by ELISA, after 24 h incubation. Data represent the mean ± SEM, \*p \< 0.05; (DMSO vs Ponatinib; n = 6, in 2 independent experiments done in duplicates, by Wilcoxon test).

To investigate the downstream pathway of NOD2 signalling, we stimulated human PBMCs in the absence or presence of Ponatinib, a drug that potently inhibits the phosphorylation of RIPK2^[@CR25]^. RIPK2 is the important kinase for the NOD2 signalling cascade^[@CR26]^. A significant reduction in TNFα, IL-1β and IL-6 production was observed when PBMCs were incubated with lysates or promastigote forms of both *L. amazonensis* and *L. braziliensis* in the presence of Ponatinib (Fig. [3C](#Fig3){ref-type="fig"}). A dose-response experiment with Ponatinib was performed and no cytotoxicity of Ponatinib to human cells or parasites was found (Fig. [S4](#MOESM1){ref-type="media"}).

NOD2 is important to control intracellular infection caused by *Leishmania* spp {#Sec6}
-------------------------------------------------------------------------------

We investigated whether NOD2 plays a role in controlling *Leishmania* spp. infection in human primary macrophages. To this end, monocyte-derived macrophages from individuals homozygous for the *NOD2* 3020insC polymorphism were compared with macrophages from healthy individuals. Both types of macrophages were infected with either promastigote forms of *L. amazonensis* or *L. braziliensis*. Figure [4A](#Fig4){ref-type="fig"} shows an increase of the macrophage infection index in cells isolated from individuals carrying the *NOD2* loss-of-function mutation compared with healthy controls (wt). Similar results were found in primary human macrophages pre-treated with Ponatinib, which showed an increase in the infection index compared to vehicle-treated macrophages (Fig. [4B](#Fig4){ref-type="fig"}). The results demonstrated that the NOD2 receptor plays an important role in the control of *Leishmania* infection in human macrophages.Figure 4NOD2 plays a role in control of Leishmania spp. infection. Monocyte-derived macrophages were obtained from PBMCs from wild type (wt) individuals (n = 4) carrying no mutations in *NOD2* receptor (3020insC) (black circles) and individuals carrying mutations in *NOD2* (n = 2, black squares) (**A**), after 5 days of differentiation. On day 5, macrophages (5 × 10^5^ cells) were infected with promastigote forms of either *L*. (*V*.) *braziliensis* and *L*. (*L*.) *amazonensis* (2.5 × 10^5^ parasites) during 4 h. (**B**) Macrophages from wt individuals (n = 4) were incubated in the absence (black balls - Vehicle DMSO) or presence (black squares) of Ponatinib (100 nM) 1 h before. Cells were washed out to remove the non-internalized parasites after 4 h, Ponatinib was added again and cells were incubated for 48 h. Coverslips were collected to determine macrophage infection index. Data represent individual values and horizontal lines represent medians. \*p \< 0.05; Wilcoxon test (DMSO vs Ponatinib).

Discussion {#Sec7}
==========

In the present study, we investigated the role of the NLR family members NOD1 and NOD2 in the induction of cytokines in human PBMCs after exposure to New World *Leishmania* spp. Results showed that whereas NOD2 plays an important role in parasite-induced cytokines, NOD1 is not relevant. Moreover, NOD2 is important for microbicidal activity of human macrophages contributing to the control of *Leishmania* spp. infection. This is the first report describing the NOD2 involvement in activation of human cells by New World *Leishmania* spp. Recently, a study in mice with *L. infantum* demonstrated that the activation of NOD2-RIP2 pathway drives the development of a Th1 instead of Th17 immune response^[@CR16]^. These results demonstrated an important role of NOD2 in controlling *Leishmania* infection.

SNPs in the *NOD2* receptor are related to autoinflammatory diseases such as Crohn's disease and Blau syndrome^[@CR27]--[@CR29]^. In general, as a consequence, individuals carrying these mutations have a reduced NF-κB activation after recognition of specific pathogen-associated NOD2 ligands, which interfere in cytokine production^[@CR30]^. Mutations in *NOD1* lead to a reduced capacity to detect their ligands^[@CR31]^. To evaluate the role of genetic variance in *NOD1* and *NOD2* in the immune response to *Leishmania* antigens, we applied a functional genomics approach as reported recently^[@CR32]--[@CR34]^. Using whole exome sequencing data of 100 subjects, we selected SNPs that are frequently present in *NOD1* or *NOD2* with a predicted loss or gain of function^[@CR35]^. Here, we showed that one particular genetic variance in *NOD2* (Leu1007finsC) downregulates the production of monocyte-derived cytokines such as TNFα, IL-1β, IL-6, IL-8 as well as IFNγ after exposure to lysates of either *L. amazonensis* or *L. braziliensis*. Remarkably, IL-17 was induced after exposure to lysates of *L. amazonensis*, but not *L. braziliensis* in a NOD2-dependent manner. The results indicate that in addition to its role in activation of the innate immunity, NOD2 shapes the adaptive immune response against *Leishmania* spp. Our results are partially in agreement with the results demonstrated by Nascimento *et al*.^[@CR16]^, in which, the authors showed that in a murine model of *L. infantum* infection, the development of Th1 responses and the production of IFNγ was dependent on NOD2. However, the authors showed that the NOD2 pathway was not relevant for Th17 development. In contrast, we demonstrated that in human PBMCs, IL-17 production is NOD2-dependent only after exposure to *L. amazonensis*. These results could be ascribed to the differences among *Leishmania* spp. as well as to differences in human and mouse immune responses^[@CR36]^. Here, besides *Leishmania* antigens (parasite lysates) or live promastigotes increased cytokines in a NOD2-dependent manner they upregulated *NOD2*, but not *NOD1* mRNA expression in PBMCs. These results strengthened the involvement of NOD2 but not NOD1 in *Leishmania* spp.-induced immune responses.

To confirm that NOD2 is relevant for *Leishmania*-induced cytokine production, we overexpressed NOD2 in HEK-293 cells and showed that these NOD2-transfected cells produced significantly higher IL-8 concentrations after exposure to parasite lysates or promastigote forms of either *L. amazonensis* or *L. braziliensis*, compared to control HEK-293 cells. Although, NOD2 is known as a receptor that recognizes structures present in the bacteria cell wall^[@CR37],[@CR38]^, the results presented here suggest that the NOD2 receptor also recognizes protozoan structures.

It is well described that PBMCs from patients with Crohn's disease carrying the *NOD2* (*NOD2* 3020insC) mutation display a reduction in cytokine production after exposure to several microbial ligands or pathogens^[@CR39],[@CR40]^. In our study, we also used PBMCs from subjects carrying *NOD2* 3020insC mutation and demonstrated a significant decrease in the production of proinflammatory cytokines after *Leishmania* spp. exposure. These data are in line with the results of the *NOD2* genetic variance Leu1007finsC and the HEK-NOD2 cells, underlining the pivotal role of NOD2 in the recognition of *Leishmania* spp.

An additional line of evidence that the NOD2 pathway is important for *Leishmania*-induced immune responses, are our results with the RIPK2 inhibitor (Ponatinib). The inhibition of RIPK2 led to almost complete abolishment of *Leishmania* cytokine production. These data demonstrate previously unknown role for human NOD2 in the recognition of *L. amazonensis* or *L. braziliensis* and make it tempting to speculate that individuals carrying *NOD2* polymorphisms might be more susceptible to ATL.

The ligand of *Leishmania* parasites that binds to NOD2 remains unknown but we showed that degradation of *Leishmania* is a prerequisite for cytokine production. Bafilomycin A1, a specific inhibitor of the phagosome acidification and blocker of phagosome maturation impaired the proinflammatory cytokine production only after exposure to live promastigote forms of *L. amazonensis* or *L. braziliensis*, whereas no effect was observed after exposure to lysates of both these species. Enzymes present in the phagolysosomes, such as lysozyme, may degrade *Leishmania* to release NOD2 ligands in a similar process that happens with *Listeria monocytogenes* ^[@CR41]^. Future studies are warranted to investigate which microbial components of *Leishmania* are recognized by NOD2.

It is known that the production of proinflammatory cytokines can play a double role in infection caused by *Leishmania* spp., contributing to the control of the infection but also favoring inflammation and tissue destruction^[@CR42],[@CR43]^. Here we demonstrated that loss of NOD2 signalling impairs intracellular *Leishmania* killing. The exact mechanisms involved in NOD2-mediated *Leishmania* killing need to be further explored, although it is known that proinflammatory cytokines promote the induction of microbicidal molecules after infection with *Leishmania* spp.^[@CR10],[@CR19]--[@CR22],[@CR44]^. Moreover, it is known that NOD2 plays an important role in induction of microbicidal mechanisms including autophagy, antimicrobial peptides and ROS production, which are essential to control infections caused by intracellular pathogens^[@CR45]--[@CR47]^.

To conclude, our study showed for the first time that the human NOD2 pathway is important for *Leishmania* recognition, the induction of innate and adaptive immune responses, and the control of intracellular killing of the parasite (Fig. [5](#Fig5){ref-type="fig"}). Our findings provide the first evidence that genetic variances in NOD2 are associated with differences in the human immune response towards *Leishmania* spp. The relevance of the NOD2 pathway in the susceptibility to or severity of human ATL needs to be investigated in the near future.Figure 5Schematic overview of the role of NOD2 receptor in *Leishmania* spp. recognition and control. (**A**) General overview of NOD2 pathway: The NOD2 receptor is engaged by its respective ligand, driving the activation of RIPK2, which is followed by NF-κB activation and translocation to the nucleus leading to inflammatory gene transcription. In addition, microbicidal molecules can be produced. NOD2 genetic variances can lead to a non-functional NOD2 receptor, as a consequence, the cytokine and microbicidal molecule production mediated by NOD2 can be affected. (**B**) Phagolysosome-mediated degradation of *Leishmania* spp. promastigote forms leads to parasite antigen release in the cytoplasm of infected cells. This may drive the NOD2 activation and subsequently induction of NF-κB gene transcription and microbicidal molecule production. *L*. (*L*.) *amazonensis* and *L*.(*V*.) *braziliensis*-NOD2-mediated proinflammatory cytokines produced by innate and adaptive cells might contribute for controlling of the infection.

Methods {#Sec8}
=======

Ethics Statement {#Sec9}
----------------

The study was approved by Ethics Committee of Radboud University Nijmegen, the Netherlands (no. 42561.091.12). Experiments were conducted according to the principles expressed in the Declaration of Helsinki. All individuals gave written informed consent to donate blood.

200FG cohort {#Sec10}
------------

Healthy individuals with a Dutch European genetic background that were recruited as part of the 200FG study^[@CR34]^ participated in the study. The volunteers were between 23--73 years old, and consisted of 77% men and 23% women.

Isolation of genomic DNA and single-nucleotide polymorphism (SNP) analysis {#Sec11}
--------------------------------------------------------------------------

DNA was isolated from whole blood by using the isolation Gentra Pure Gene Blood kit (Qiagen), according to the manufacturer's protocol. SNPs in the analyzed receptor genes were selected from the National Center for Biotechnology Information SNP database (<http://www.ncbi.nlm.nih.gov/snp/>) upon previously described associations with human diseases and a minor allele frequency of at least 5% among different populations. In total, 7 SNPs in *NOD1* and *NOD2* receptors were selected and genotyped (Supplementary Table 1). Gene fragments were amplified by commercially available TaqMan® SNP Genotyping Assays according to the manufacturer's protocol on the AB StepOnePlus polymerase chain reaction system (Applied Biosystems). Quality control was performed by the incorporation of positive and negative controls and duplication of random samples across different plates.

*Leishmania* cultures and lysates {#Sec12}
---------------------------------

*L. amazonensis* (IFLA/BR/67/PH8) reference strain and MHOM/BR/2003/IMG *L. braziliensis*, a clinical isolate obtained from a LCL patient (Leishbank IPTSP/UFG)^[@CR48]^, were used. Promastigote forms were cultured in Grace's Insect Medium, (Gibco - Life Technologies) and prepared for experiments as described by dos Santos *et al*.^[@CR19]^. To obtain lysates of *Leishmania*, promastigotes (1 × 10^9^ cells/mL) were lysed by 5 freeze-thaw cycles in liquid nitrogen and water bath at 37 °C followed by protein quantification using the Pierce BCA protein assay (Thermo Scientific). For cell stimulations, parasites were suspended in RPMI 1640 medium (Sigma) and added to the cultures as described below.

Human embryonic kidney cell line (HEK) stimulation {#Sec13}
--------------------------------------------------

Transfection of HEK-293 cells with human *NOD2* was performed as previously described by Laayouni *et al*.^[@CR49]^ and culture conditions are described as supplementary material. Non-transfected or NOD2-transfected HEK-293 cells (1 × 10^6^ cells) were added to 96-well flat-bottom plates (Greiner) in the presence of either *E. coli* lipopolysaccharide (LPS, O111:B4, 10 ng/mL; Sigma), further purified based on^[@CR50]^, muramyl dipeptide (MDP, 10 μg/mL; Sigma), lysates or promastigotes (2 × 10^6^ parasites) of *L. braziliensis* or *L. amazonensis* in a final volume of 200 μL. After 24 h of incubation, at 37 °C and 5% CO~2~, supernatants were collected and stored at −20 °C until analysis of IL-8 production.

Isolation of human peripheral blood mononuclear cells (PBMC) and treatments {#Sec14}
---------------------------------------------------------------------------

Venous blood was obtained from eight healthy individuals bearing the wild-type allele of *NOD2* (wild type, wt) and from four homozygous individuals for the *NOD2* 3020insC mutation presenting Crohn's disease. Isolation of PBMCs was performed as described previously^[@CR39]^, by density gradient centrifugation of blood diluted 1:1 in pyrogen-free saline overlayed on Ficoll-Paque (Pharmacia Biotech). PBMCs were suspended in RPMI 1640 medium with 50 mg/mL gentamicin, 2 mmol/L L-glutamine, and 1 mmol/L pyruvate (Invitrogen). The number was adjusted to 5 × 10^6^ cells/mL. Cells (5 × 10^5^ cells/mL) were added to round-bottom 96-well plates (Greiner) and incubated with either culture medium (negative control), MDP (10 μg/ml), FK-156 (10 μg/mL, Sigma), ultra-pure *E. coli* LPS as described by Battisti & Minnick^[@CR50]^ (O111:B4 serotype, 10 ng/mL; Sigma) or 50 μg/mL of both *Leishmania* pp. lysates or promastigotes (1 × 10^5^ parasites) of *L. braziliensis* and *L. amazonensis* in the presence or absence of 10% of human pool serum. In some experiments, PBMCs were pre-incubated for 1 h with a RICK inhibitor (Ponatinib, 100 nM/mL; Selleckchem) and a phagolysosome inhibitor (Bafilomycin A1, 250 nM; Invivogen) before cells were stimulated with lysates or promastigotes. After 24 h or 7 days, the supernatants were collected and stored at −20 °C until further analysis. The cell monolayers were collected by adding 200 µL of TRIzol and stored at −80 °C until being used for mRNA extraction.

Measurement of cytokines {#Sec15}
------------------------

Human TNFα, IL-1β, IL-6, IL-8, IL-17A and IFNγ were determined in culture supernatants using commercial Enzyme-Linked Immunosorbent Assay (ELISA) kits (Sanquin, Amsterdam, and R&D Systems, Minneapolis), according to the manufacturer's protocols.

Evaluation of mRNA expression by quantitative real-time PCR (qPCR) {#Sec16}
------------------------------------------------------------------

RNA isolation was carried out based on the method reported by Chomzynski & Sacchi^[@CR51]^ and the qPCR method is shortly described in supplementary material. Primer sequences (Supplementary Table 2) for *NOD1* and *NOD2* receptors were obtained from the Harvard Primerbank database. Primers were purchased from Biolegio. Relative expression of mRNA levels was calculated and normalized for the housekeeping gene GAPDH.

Evaluation of Macrophage infection {#Sec17}
----------------------------------

Monocyte-derived macrophages from healthy volunteers and from homozygous individuals for the *NOD2* 3020insC mutation were obtained from PBMCs (5 × 10^5^ cells/well) during 5 days at 37 °C, 5% CO~2~. PBMCs were counted and plated into 24-well plates (Costar) over coverslips in the presence of RPMI-1640 medium supplemented as described above and added with 10% of human pool serum. Medium was refreshed every 48 h. On day 5, macrophages were infected with promastigote forms of either *L. braziliensis* or *L*. *amazonensis* (2.5 × 10^5^ parasites) during 4 h. Cells were washed to remove non-internalized parasites and incubated for 48 h. Additionally, is some experiments monocyte-derived macrophages were pre-treated or not with Ponatinib (100 nM/mL; Selleckchem) 1 h before infection and the drug was replaced after washings. Coverslips were collected to determine the macrophage infection index after cells were fixed and stained with Giemsa (Merck Millipore), according to^[@CR52]^ and briefly described in supplementary material.

Statistical Analysis {#Sec18}
--------------------

Data are expressed as median, interquartile, minimal and maximal values, unless otherwise indicated. Differences between experimental groups were tested by Mann-Whitney *U* test or unpaired t test according to the data, or by Wilcoxon paired test, using Prism software (version 6.0; GraphPad; San Diego, CA, USA). Differences with *p* \< 0. 05 were considered significant.
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